Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy

Core Insights - Nuwellis, Inc. has announced a new partnership with a nationally ranked pediatric hospital in Utah, marking its 44th pediatric account, to utilize the Aquadex SmartFlow system for treating fluid overload in children [1][2][3] - The Aquadex SmartFlow system is designed to provide advanced therapy for fluid management, particularly beneficial for pediatric patients suffering from severe kidney and heart conditions [2][3] - Since receiving FDA clearance in 2020, Nuwellis has significantly expanded its accounts from 13 to 44, demonstrating strong growth in its pediatric business [1][3] Company Overview - Nuwellis, Inc. is a medical technology company focused on transforming the lives of patients suffering from fluid overload through innovative solutions like the Aquadex SmartFlow system [5] - The company is headquartered in Minneapolis and has a wholly owned subsidiary in Ireland, emphasizing its commitment to expanding access to its therapies for both pediatric and adult patients [5][4] Product Details - The Aquadex SmartFlow system is an ultrafiltration therapy device that safely and predictably removes excess fluid from patients, helping them regain fluid balance in critical care situations [3][6] - It is indicated for temporary or extended use in patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics [6]